Cargando…
Remifentanil Protects against Lipopolysaccharide-Induced Inflammation through PARP-1/NF-κB Signaling Pathway
Sepsis is a leading cause of death in patients with severe infection worldwide. Remifentanil is an ultra-short-acting, potent opioid analgesic. In the study, we aimed to investigate the role and underlying mechanism of remifentanil in lipopolysaccharide- (LPS-) induced inflammation in human aortic e...
Autores principales: | Zhang, Jian-ning, Ma, Yang, Wei, Xi-yan, Liu, Ke-yin, Wang, Hao, Han, Hui, Cui, Yi, Zhang, Ming-xiang, Qin, Wei-dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012251/ https://www.ncbi.nlm.nih.gov/pubmed/32082073 http://dx.doi.org/10.1155/2019/3013716 |
Ejemplares similares
-
Adrenomedullin protects Leydig cells against lipopolysaccharide-induced oxidative stress and inflammatory reaction via MAPK/NF-κB signalling pathways
por: Hu, Wei, et al.
Publicado: (2017) -
Tim-3 protects against cisplatin nephrotoxicity by inhibiting NF-κB-mediated inflammation
por: Li, Peiyao, et al.
Publicado: (2023) -
Correction: Tim-3 protects against cisplatin nephrotoxicity by inhibiting NF-κB-mediated inflammation
por: Li, Peiyao, et al.
Publicado: (2023) -
PARP2 downregulation in T cells ameliorates lipopolysaccharide-induced inflammation of the large intestine
por: Bencsics, Máté, et al.
Publicado: (2023) -
Monascin ameliorate inflammation in the lipopolysaccharide-induced BV-2 microglial cells via suppressing the NF-κB/p65 pathway
por: Shi, Yong-Xiang, et al.
Publicado: (2020)